合成路线1
该中间体在本合成路线中的序号:
(IV) 1) The cyclization of ethyl 3(S)-hydroxybutanoate (I) with N-anisylcinnamylideneamine (II) gives 1-(4-anisyl)-3alpha-[1(S)-hydroxyethyl]-4-(2-phenylvinyl)azetidin-2-one (III), which is esterified with thiocarbonyldiimidazole (IV) yielding the thioester (V). The reduction of (V) with NaBH4 in hot DMSO affords 1-(4-anisyl)-3alpha-ethyl-4-(2-phenylvinyl)azetidin-2-one (VI), which is oxidized with KMnO4 - NaClO4, giving the carboxylic acid (VII). The oxidative decarboxylation of (VII) with lead tetraacetate yields 4-acetoxy-1-(4-anisyl)-3alpha-ethylazetidin-2-one (VIII), which is submitted to dearylation with ammonium cerium (IV) nitrate to afford 4-acetoxy-3alpha-ethylazetidin-2-one (IX). The condensation of (IX) with 4-nitrobenzyl 2-diazo-3-(tert-butyldimethylsilyloxy)-3-butenoate (X) gives the diazo keto ester (XI), which is cyclized yielding 4-nitrobenzyl 6-ethyl-3,7-dioxo-1-azabicyclo[3.2.0]heptane-2-carboxylate (XII). The reaction of (XII) with diphenyl chlorophosphate affords the enol phosphate (XIII), which is condensed with N-acetylcysteamine (XIV) to give 4-nitrobenzyl ester of PS-5 (XV). Finally, this compound is deprotected by hydrogenation with H2 over Pd/C.
【1】
Georg, G.I.; Kant, J.; An asymmetric synthesis of carbapenem antibiotic (+)-PS-5 from ethyl 3-hydroxybutanoate. J Org Chem 1988, 53, 3, 692-5.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
|
16074 |
Diphenyl phosphoryl chloride; 1,1'-Diphenylphosphoryl chloride; Chlorodiphenyl Phosphate; Diphenyl chlorophosphate; Diphenylchlorophosphate
|
2524-64-3 |
C12H10ClO3P |
详情 | 详情
|
|
44204 |
N,N-diethyl-2-propanamine; N,N-diethyl-N-isopropylamine
|
|
C7H17N |
详情 |
详情
|
(I) |
20021 |
(3S)-3-Hydroxybutanoic acid ethyl ester
|
56816-01-4 |
C6H12O3 |
详情 | 详情
|
(II) |
20022 |
4-methoxy-N-[(Z,2E)-3-phenyl-2-propenylidene]aniline; N-(4-methoxyphenyl)-N-[(Z,2E)-3-phenyl-2-propenylidene]amine
|
|
C16H15NO |
详情 |
详情
|
(III) |
20023 |
(3S)-3-(1-hydroxyethyl)-1-(4-methoxyphenyl)-4-[(E)-2-phenylethenyl]-2-azetidinone
|
|
C20H21NO3 |
详情 |
详情
|
(IV) |
11990 |
Di(1H-imidazol-1-yl)methanethione; 1,1'-Thiocarbonyldiimidazole
|
6160-65-2 |
C7H6N4S |
详情 | 详情
|
(V) |
20025 |
O-(1-[(3S)-1-(4-methoxyphenyl)-2-oxo-4-[(E)-2-phenylethenyl]azetidinyl]ethyl) 1H-imidazole-1-carbothioate
|
|
C24H23N3O3S |
详情 |
详情
|
(VI) |
20026 |
(3R)-3-ethyl-1-(4-methoxyphenyl)-4-[(E)-2-phenylethenyl]-2-azetidinone
|
|
C20H21NO2 |
详情 |
详情
|
(VII) |
20027 |
(3R)-3-ethyl-1-(4-methoxyphenyl)-4-oxo-2-azetidinecarboxylic acid
|
|
C13H15NO4 |
详情 |
详情
|
(VIII) |
20028 |
(3R)-3-ethyl-1-(4-methoxyphenyl)-4-oxoazetidinyl acetate
|
|
C14H17NO4 |
详情 |
详情
|
(IX) |
20029 |
(3R)-3-ethyl-4-oxoazetidinyl acetate
|
|
C7H11NO3 |
详情 |
详情
|
(X) |
20030 |
2-Diazo-3-(tert-butyldimethylsilyloxy)-3-butenoic acid 4-nitrobenzyl ester
|
|
C17H23N3O5Si |
详情 |
详情
|
(XI) |
20031 |
(2R,3R)-2-Diazo-4-(3-ethyl-4-oxoazetidin-2-yl)-3-oxobutyric acid 4-nitrobenzyl ester
|
|
C16H16N4O6 |
详情 |
详情
|
(XII) |
20032 |
4-nitrobenzyl (5R,6R)-6-ethyl-3,7-dioxo-1-azabicyclo[3.2.0]heptane-2-carboxylate
|
|
C16H16N2O6 |
详情 |
详情
|
(XIII) |
20033 |
4-nitrobenzyl (5R,6R)-3-[(diphenoxyphosphoryl)oxy]-6-ethyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate
|
|
C28H25N2O9P |
详情 |
详情
|
(XIV) |
20034 |
N-(2-sulfanylethyl)acetamide
|
1190-73-4 |
C4H9NOS |
详情 | 详情
|
(XV) |
20035 |
4-nitrobenzyl (5R,6R)-3-[[2-(acetamido)ethyl]sulfanyl]-6-ethyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate
|
|
C20H23N3O6S |
详情 |
详情
|
合成路线2
该中间体在本合成路线中的序号:
(III) This compound is prepared by two related ways:
1) The partial silylation of adenosine (I) with tert-butyldimethylsilyl chloride and imidazole gives 5'-O-(tert-butyldimethylsilyl)adenosine (II), which by reaction with 1,1'-thiocarbonyldiimidazole (III) in hot DMF is converted into 5'-O-(tert-butyldimethylsilyl)-2',3'-O-thionocarbonyladenosine (IV). The desulfurization of (IV) with 1,3-dimethyl-2-phenyl-1,3,2-diazaphospholidine (V) or triethyl phosphite in THF yields 5'-O-(tert-butyldimethylsilyl)-2',3'-didehydro-2',3'-dideoxyadenosine (VI), which is deprotected with tetrabutylammonium fluoride in THF affording 2',3'-didehydro-2',3'-dideoxyadenosine (VII). Finally, this compound is hydrogenated with H2 over Pd/C in methanol.
2) The reaction of silylated adenosine (II) with CS2 and NaOH in DMSO, followed by methylation with methyl iodide gives 5'-O-(tert-butyldimethylsilyl)-2',3'-bis-O-[(methylthio)thiocarbonyl]ad enosine (VIII), which is desulfurized with tributyltin hydride and AIBN in refluxing toluene to yield the dideoxy-didehydroadenosine (VI), already obtained.
【1】
Chu, C.K.; Bhadti, V.S.; Doboszewski, B.; Gu, Z.P.; Kosugi, Y.; Pullaiah, K.C.; Van Roey, P.; General syntheses of 2',3'-dideoxynucleosides and 2',3'-didehydro-2',3'-dideoxynucleosides. J Org Chem 1989, 54, 2217-25.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
11988 |
Adenosine; (2R,3R,4S,5R)-2-(6-Amino-9H-purin-9-yl)-5-(hydroxymethyl)tetrahydro-3,4-furandiol
|
58-61-7 |
C10H13N5O4 |
详情 | 详情
|
(II) |
11989 |
(2R,3R,4S,5R)-2-(6-Amino-9H-purin-9-yl)-5-([[tert-butyl(dimethyl)silyl]oxy]methyl)tetrahydro-3,4-furandiol
|
|
C16H27N5O4Si |
详情 |
详情
|
(III) |
11990 |
Di(1H-imidazol-1-yl)methanethione; 1,1'-Thiocarbonyldiimidazole
|
6160-65-2 |
C7H6N4S |
详情 | 详情
|
(IV) |
11991 |
(3aR,4R,6R,6aR)-4-(6-Amino-9H-purin-9-yl)-6-([[tert-butyl(dimethyl)silyl]oxy]methyl)tetrahydrofuro[3,4-d][1,3]dioxole-2-thione
|
|
C17H25N5O4SSi |
详情 |
详情
|
(V) |
11992 |
1,3-Dimethyl-2-phenyl-1,3,2-diazaphospholane; 1,3-DIMETHYL-2-PHENYL-1,3,2-DIAZAPHOSPHOLIDINE
1,3-Dimethy?2-phenyl-1,3,2-diazaphospholidine
|
22429-12-5 |
C10H15N2P |
详情 | 详情
|
(VI) |
11993 |
9-[(2R,5S)-5-([[tert-Butyl(dimethyl)silyl]oxy]methyl)-2,5-dihydro-2-furanyl]-9H-purin-6-ylamine; 9-[(2R,5S)-5-([[tert-Butyl(dimethyl)silyl]oxy]methyl)-2,5-dihydro-2-furanyl]-9H-purin-6-amine
|
|
C16H25N5O2Si |
详情 |
详情
|
(VII) |
11994 |
[(2S,5R)-5-(6-Amino-9H-purin-9-yl)-2,5-dihydro-2-furanyl]methanol
|
7057-48-9 |
C10H11N5O2 |
详情 | 详情
|
(VIII) |
11995 |
O-((2R,3R,4R,5R)-2-(6-Amino-9H-purin-9-yl)-5-([[tert-butyl(dimethyl)silyl]oxy]methyl)-4-[[(methylsulfanyl)carbothioyl]oxy]tetrahydro-3-furanyl) S-methyl carbonodithioate
|
|
C20H31N5O4S4Si |
详情 |
详情
|
合成路线3
该中间体在本合成路线中的序号:
(III) Compound (I) as a 2:1 mixture of diastereoisomers was hydrolyzed with barium hydroxide to afford a mixture of alcohols (II). Further reaction with thiocarbonyldiimidazole (III) and dimethylamino-pyridine (DMAP) gave thiocarbamate (IV), which was finally reduced with tributyltin hydride and azabis(isobutyronitrile) (AIBN) in refluxing benzene.
【1】
Unno, R.; et al.; Structure-activity relationships of cyclic enediynes related to dynemicin A-II. Synthesis and antitumor activity of 9- and 12-substituted enediynes equipped with aryl carbamate moieties. Bioorg Med Chem 1997, 5, 5, 903.
|
【2】
Unno, R.; et al.; Structure-activity relationships of cyclic enediynes related to dynemicin A-I. Synthesis and antitumor activity of 9-acetoxy enediynes equipped with aryl carbamate moieties. Bioorg Med Chem 1997, 5, 5, 883.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
17773 |
4-chlorophenyl (1R,9S,16R,18S)-16-(acetoxy)-17-oxa-8-azatetracyclo[7.7.2.0(1,18).0(2,7)]octadeca-2,4,6,12-tetraene-10,14-diyne-8-carboxylate
|
|
C25H16ClNO5 |
详情 |
详情
|
(II) |
17774 |
4-chlorophenyl (1S,9S,16R,18S)-16-hydroxy-17-oxa-8-azatetracyclo[7.7.2.0(1,18).0(2,7)]octadeca-2,4,6,12-tetraene-10,14-diyne-8-carboxylate
|
|
C23H14ClNO4 |
详情 |
详情
|
(III) |
11990 |
Di(1H-imidazol-1-yl)methanethione; 1,1'-Thiocarbonyldiimidazole
|
6160-65-2 |
C7H6N4S |
详情 | 详情
|
(IV) |
17776 |
4-chlorophenyl (1R,9S,16R,18S)-16-[(1H-imidazol-1-ylcarbothioyl)oxy]-17-oxa-8-azatetracyclo[7.7.2.0(1,18).0(2,7)]octadeca-2,4,6,12-tetraene-10,14-diyne-8-carboxylate
|
|
C27H16ClN3O4S |
详情 |
详情
|
合成路线4
该中间体在本合成路线中的序号:
(V) The hydrolysis of 6,7-dichloro-3-nitro-2-naphthoic acid ethyl ester (I) with NaOH in ethanol gives the expected free acid (II), which is treated with diphenylphosphoroazidate and triethylamine in DMF to yield 6,7-dichloro-3-nitro-2-naphthylamine (III). The reduction of (III) with H2 over RaNi in ehanol/ethyl acetate affords the corresponding diamine (IV), which is cyclized with thiocarbonyldi-imidazole (V) in refluxing benzene to give 6,7-dichloro-2,3-dihydro-1H-naphtho[2,3-d]imidazole-2-thione (VI). The methylation of (VI) with methyl iodide in dry DMF yields the corresponding methylsulfanyl derivative (VII), which is condensed with 1-O-acetyl-2,3,5-tri-O-ben-zoyl-beta-D-ribofuranose (VIII) by means of trimethylsilyl trifluoro-methanesulfonate (TMSOTf) and N,O-bis(trimethylsilyl)acetamide (BSA) in dichloromethane affording the benzoylated ribofuranoside (IX). The debenzoylation of (IX) with ammonia in methanol gives the free ribofuranoside (X), which is finally treated with Cl2/CCl4 in methanol to eliminate the methylsulfanyl group.
【1】
Zhu, Z.J.; et al.; Synthesis of 2,6, 7-trichloro-1-(beta-D-ribofuranosyl)naphtho[2, 3-d]imidazole: A linear dimensional analogue of the antiviral agent TCRB. J Org Chem 1998, 63, 4, 977.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
26976 |
ethyl 6,7-dichloro-3-nitro-2-naphthoate
|
|
C13H9Cl2NO4 |
详情 |
详情
|
(II) |
26977 |
6,7-dichloro-3-nitro-2-naphthoic acid
|
|
C11H5Cl2NO4 |
详情 |
详情
|
(III) |
26978 |
6,7-dichloro-3-nitro-2-naphthalenamine
|
|
C10H6Cl2N2O2 |
详情 |
详情
|
(IV) |
26979 |
3-amino-6,7-dichloro-2-naphthylamine
|
|
C10H8Cl2N2 |
详情 |
详情
|
(V) |
11990 |
Di(1H-imidazol-1-yl)methanethione; 1,1'-Thiocarbonyldiimidazole
|
6160-65-2 |
C7H6N4S |
详情 | 详情
|
(VI) |
26980 |
6,7-dichloro-1,3-dihydro-2H-naphtho[2,3-d]imidazole-2-thione
|
|
C11H6Cl2N2S |
详情 |
详情
|
(VII) |
26981 |
6,7-dichloro-1H-naphtho[2,3-d]imidazol-2-yl methyl sulfide
|
|
C12H8Cl2N2S |
详情 |
详情
|
(VIII) |
26984 |
(2R,3R,4R,5S)-5-(acetoxy)-4-(benzoyloxy)-2-[(benzoyloxy)methyl]tetrahydro-3-furanyl benzoate
|
|
C28H24O9 |
详情 |
详情
|
(IX) |
26982 |
(2R,3R,4R,5R)-4-(benzoyloxy)-2-[(benzoyloxy)methyl]-5-[6,7-dichloro-2-(methylsulfanyl)-1H-naphtho[2,3-d]imidazol-1-yl]tetrahydro-3-furanyl benzoate
|
|
C38H28Cl2N2O7S |
详情 |
详情
|
(X) |
26983 |
(2R,3R,4S,5R)-2-[6,7-dichloro-2-(methylsulfanyl)-1H-naphtho[2,3-d]imidazol-1-yl]-5-(hydroxymethyl)tetrahydro-3,4-furandiol
|
|
C17H16Cl2N2O4S |
详情 |
详情
|
合成路线5
该中间体在本合成路线中的序号:
(II) Condensation of 2-amino-5-bromopyridine (I) with 1,1-thiocarbonyl diimidazole (II) furnished the thiocarbonyl derivative (III). Further reaction of (III) with 1-(2-aminoethyl)piperidine (IV) gave the target thiourea.
【1】
Mao, C.; Vig, R.; Venkatachalam, T.K.; Sudbeck, E.A.; Uckun, F.M.; Structure-based design of N-[2-(1-piperidinylethyl)]-N'-[2-(5-bromopyridyl)]-thiourea and N-[2-(1-piperazinylethyl)]-N'-[2-(5-bromopyridyl)]-thiourea as potent non-nucleoside inhibitors of HIV-1 reverse transcriptase. Bioorg Med Chem Lett 1998, 8, 16, 2213. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
12123 |
5-Bromo-2-pyridinylamine; 5-Bromo-2-pyridinamine; 2-Amino-5-bromopyridine
|
1072-97-5 |
C5H5BrN2 |
详情 | 详情
|
(II) |
11990 |
Di(1H-imidazol-1-yl)methanethione; 1,1'-Thiocarbonyldiimidazole
|
6160-65-2 |
C7H6N4S |
详情 | 详情
|
(III) |
24645 |
N-(5-bromo-2-pyridinyl)-1H-imidazole-1-carbothioamide
|
|
C9H7BrN4S |
详情 |
详情
|
(IV) |
24646 |
2-(1-piperidinyl)-1-ethanamine
|
27578-60-5 |
C7H16N2 |
详情 | 详情
|
合成路线6
该中间体在本合成路线中的序号:
(II) Condensation of 2-amino-5-bromopyridine (I) with 1,1-thiocarbonyl diimidazole (II) furnished the thiocarbonyl derivative (III). Further reaction of (III) with 1-(2-aminoethyl)piperazine (IV) gave the target thiourea.
【1】
Mao, C.; Vig, R.; Venkatachalam, T.K.; Sudbeck, E.A.; Uckun, F.M.; Structure-based design of N-[2-(1-piperidinylethyl)]-N'-[2-(5-bromopyridyl)]-thiourea and N-[2-(1-piperazinylethyl)]-N'-[2-(5-bromopyridyl)]-thiourea as potent non-nucleoside inhibitors of HIV-1 reverse transcriptase. Bioorg Med Chem Lett 1998, 8, 16, 2213. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
12123 |
5-Bromo-2-pyridinylamine; 5-Bromo-2-pyridinamine; 2-Amino-5-bromopyridine
|
1072-97-5 |
C5H5BrN2 |
详情 | 详情
|
(II) |
11990 |
Di(1H-imidazol-1-yl)methanethione; 1,1'-Thiocarbonyldiimidazole
|
6160-65-2 |
C7H6N4S |
详情 | 详情
|
(III) |
24645 |
N-(5-bromo-2-pyridinyl)-1H-imidazole-1-carbothioamide
|
|
C9H7BrN4S |
详情 |
详情
|
(IV) |
24647 |
2-(1-piperazinyl)-1-ethanamine
|
140-31-8 |
C6H15N3 |
详情 | 详情
|
合成路线7
该中间体在本合成路线中的序号:
(II) 2-Amino-5-bromopyridine (I) was condensed with 1,1-thiocarbonyldiimidazole (II) in acetonitrile to furnish the precursor thiocarbonyl derivative (III). Further reaction of (III) with 2-chlorophenethylamine (IV) in DMF at 100 C gave the target thiourea.
【1】
Vig, R.; Mao, C.; Venkatachalam, T.K.; Tuel-Ahlgren, L.; Sudbeck, E.A.; Uckun, F.M.; Rational design and synthesis of phenethyl-5-bromopyridyl thiourea derivatives as potent non-nucleoside inhibitors of HIV reverse transcriptase. Bioorg Med Chem 1998, 6, 10, 1789. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
12123 |
5-Bromo-2-pyridinylamine; 5-Bromo-2-pyridinamine; 2-Amino-5-bromopyridine
|
1072-97-5 |
C5H5BrN2 |
详情 | 详情
|
(II) |
11990 |
Di(1H-imidazol-1-yl)methanethione; 1,1'-Thiocarbonyldiimidazole
|
6160-65-2 |
C7H6N4S |
详情 | 详情
|
(III) |
26465 |
methyl (2S,3R)-3-cyclopropyl-2,3-dihydroxypropanoate
|
|
C7H12O4 |
详情 |
详情
|
(IV) |
31334 |
2-chlorophenethylamine; 2-(2-chlorophenyl)-1-ethanamine
|
13078-80-3 |
C8H10ClN |
详情 | 详情
|
合成路线8
该中间体在本合成路线中的序号:
(II) 2-Amino-5-bromopyridine (I) was condensed with 1,1-thiocarbonyldiimidazole (II) in acetonitrile to furnish the precursor thiocarbonyl derivative (III). Further reaction of (III) with 3-chlorophenethylamine (IV) in DMF at 100 C gave the target thiourea.
【1】
Vig, R.; Mao, C.; Venkatachalam, T.K.; Tuel-Ahlgren, L.; Sudbeck, E.A.; Uckun, F.M.; Rational design and synthesis of phenethyl-5-bromopyridyl thiourea derivatives as potent non-nucleoside inhibitors of HIV reverse transcriptase. Bioorg Med Chem 1998, 6, 10, 1789. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
12123 |
5-Bromo-2-pyridinylamine; 5-Bromo-2-pyridinamine; 2-Amino-5-bromopyridine
|
1072-97-5 |
C5H5BrN2 |
详情 | 详情
|
(II) |
11990 |
Di(1H-imidazol-1-yl)methanethione; 1,1'-Thiocarbonyldiimidazole
|
6160-65-2 |
C7H6N4S |
详情 | 详情
|
(III) |
26465 |
methyl (2S,3R)-3-cyclopropyl-2,3-dihydroxypropanoate
|
|
C7H12O4 |
详情 |
详情
|
(IV) |
31335 |
3-chlorophenethylamine; 2-(3-chlorophenyl)-1-ethanamine
|
13078-79-0 |
C8H10ClN |
详情 | 详情
|
合成路线9
该中间体在本合成路线中的序号:
(II) By condensation of 2-(4-chlorophenyl)ethylamine (I) with thiocarbonyldiimidazole (II) in refluxing acetonitrile.
【1】
Zhu, Z.; et al.; N,N'-Di(phenethyl)thiourea liquid-phase combinatorial libraries: Synthesis and apoptosis induction. 217th ACS Natl Meet (March 21 1999, Anaheim) 1999, Abst MEDI 023.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
29459 |
4-chlorophenethylamine; 2-(4-chlorophenyl)-1-ethanamine
|
156-41-2 |
C8H10ClN |
详情 | 详情
|
(II) |
11990 |
Di(1H-imidazol-1-yl)methanethione; 1,1'-Thiocarbonyldiimidazole
|
6160-65-2 |
C7H6N4S |
详情 | 详情
|
合成路线10
该中间体在本合成路线中的序号:
(II) 2-Amino-5-bromopyridine (I) was condensed with 1,1-thiocarbonyldiimidazole (II) in acetonitrile to furnish the precursor thiocarbonyl derivative (III). Further reaction of (III) with 2-fluorophenethylamine (IV) in DMF at 100 C gave the target thiourea.
【1】
Vig, R.; Mao, C.; Venkatachalam, T.K.; Tuel-Ahlgren, L.; Sudbeck, E.A.; Uckun, F.M.; Rational design and synthesis of phenethyl-5-bromopyridyl thiourea derivatives as potent non-nucleoside inhibitors of HIV reverse transcriptase. Bioorg Med Chem 1998, 6, 10, 1789. |
【2】
Uckun, F.M. (Parker Hughes Institute); NNI for treatment of multi-drug resistant HIV. WO 0056736 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
12123 |
5-Bromo-2-pyridinylamine; 5-Bromo-2-pyridinamine; 2-Amino-5-bromopyridine
|
1072-97-5 |
C5H5BrN2 |
详情 | 详情
|
(II) |
11990 |
Di(1H-imidazol-1-yl)methanethione; 1,1'-Thiocarbonyldiimidazole
|
6160-65-2 |
C7H6N4S |
详情 | 详情
|
(III) |
26465 |
methyl (2S,3R)-3-cyclopropyl-2,3-dihydroxypropanoate
|
|
C7H12O4 |
详情 |
详情
|
(IV) |
31333 |
2-fluorophenethylamine; 2-(2-fluorophenyl)-1-ethanamine
|
|
C8H10FN |
详情 |
详情
|
合成路线11
该中间体在本合成路线中的序号:
(II) The reaction of 5-bromopyridin-2-amine (I) with thiocarbonyldiimidazole (II) in acetonitrile gives the thioamide (III), which is finally condensed with 2-(2,5-dimethoxyphenyl)ethylamine (IV) in DMF at 100 C.
【1】
Vig, R.; Mao, C.; Venkatachalam, T.K.; Tuel-Ahlgren, L.; Sudbeck, E.A.; Uckun, F.M.; Rational design and synthesis of phenethyl-5-bromopyridyl thiourea derivatives as potent non-nucleoside inhibitors of HIV reverse transcriptase. Bioorg Med Chem 1998, 6, 10, 1789. |
【2】
Uckun, F.M. (Parker Hughes Institute); NNI for treatment of multi-drug resistant HIV. WO 0056736 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
12123 |
5-Bromo-2-pyridinylamine; 5-Bromo-2-pyridinamine; 2-Amino-5-bromopyridine
|
1072-97-5 |
C5H5BrN2 |
详情 | 详情
|
(II) |
11990 |
Di(1H-imidazol-1-yl)methanethione; 1,1'-Thiocarbonyldiimidazole
|
6160-65-2 |
C7H6N4S |
详情 | 详情
|
(III) |
24645 |
N-(5-bromo-2-pyridinyl)-1H-imidazole-1-carbothioamide
|
|
C9H7BrN4S |
详情 |
详情
|
(IV) |
36889 |
2,5-dimethoxyphenethylamine; 2-(2,5-dimethoxyphenyl)-1-ethanamine
|
3600-86-0 |
C10H15NO2 |
详情 | 详情
|
合成路线12
该中间体在本合成路线中的序号:
(II) 2-Amino-5-bromopyridine (I) was condensed with 1,1-thiocarbonyldiimidazole (II) in acetonitrile to furnish the precursor thiocarbonyl derivative (III). Further reaction of (III) with 3-fluorophenethylamine (IV) in DMF at 100 C gave the target thiourea.
【1】
Vig, R.; Mao, C.; Venkatachalam, T.K.; Tuel-Ahlgren, L.; Sudbeck, E.A.; Uckun, F.M.; Rational design and synthesis of phenethyl-5-bromopyridyl thiourea derivatives as potent non-nucleoside inhibitors of HIV reverse transcriptase. Bioorg Med Chem 1998, 6, 10, 1789. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
12123 |
5-Bromo-2-pyridinylamine; 5-Bromo-2-pyridinamine; 2-Amino-5-bromopyridine
|
1072-97-5 |
C5H5BrN2 |
详情 | 详情
|
(II) |
11990 |
Di(1H-imidazol-1-yl)methanethione; 1,1'-Thiocarbonyldiimidazole
|
6160-65-2 |
C7H6N4S |
详情 | 详情
|
(III) |
26465 |
methyl (2S,3R)-3-cyclopropyl-2,3-dihydroxypropanoate
|
|
C7H12O4 |
详情 |
详情
|
(IV) |
31336 |
3-fluorophenethylamine; 2-(3-fluorophenyl)-1-ethanamine
|
|
C8H10FN |
详情 |
详情
|
合成路线13
该中间体在本合成路线中的序号:
(A) Condensation of protected ketone (I) with 2-benzyloxy-1-trimethylsilyloxyphenoxyethane (II) by means of Sn(OTf)2 and chiral amine (III) in propionitrile affords aldolic reaction product (IV), which is then dehydroxylated by treatment with thiocarbonyl diimidazole (A) in THF followed by reduction with Bu3SnH in refluxing toluene to provide the protected hydroxyester (V). Reduction of the ester group of (V) with DIBAL in CH2Cl2 followed by Swern oxidation with (COCl)2, DMSO and Et3N in dichloromethane yields aldehyde (VI), which is then condensed with 2-methoxypropene (VII) and 2-methoxyaniline (VIII) in the presence of yterbium triflate (Yb(OTf)3) in THF/H2O to furnish a mixture of diastereoisomers from which anti-(IX) is separated. Derivative anti-(IX) is treated with HF in THF for TBS removal and cyclization is induced by reaction with PPh3 and CBr4 in CH2Cl2, affording piperidine (X). Next, treatment of (X) with cerium ammonium nitrate (CAN) in acetonitrile/H2O allows N-protecting group removal, giving piperidine derivative (XI).
Alternatively, (XI) can be obtained as follows: Treatment of aldehyde (VI) with 2-methoxyaniline (VIII) and PMB-protected 2-methoxypropene (XII) in the presence of scandium trisdodecylsulfate (STDS) in THF/H2O yields a mixture of diastereoisomers from which anti-(XIII) is separated. Derivative anti-(XIII) is then converted into (XI) by following the same procedure as for the conversion of anti-(IX) into (XI). Derivative (XI) is then subjected to: (i) N-protection by means of Boc2O; (ii) treatment with lithium hexamethyl disilazide (LHMDS) followed by trimethylsilyl chloride (TMSCl); (iii) oxidation of the silylenol ether by means of MCPBA; and (iv) bromination with PPh3 and CBr4. After all these steps bromo derivative (XIV) is obtained. Finally, coupling of (XIV) with 4-hydroxyquinazoline (XV) using KOH followed by Boc removal by treatment with refluxing HCl furnishes the target compound.
【1】
Wataya, Y.; Ueno, M.; Suzuki, R.; Kim, H.-S.; Kobayashi, S.; Ishitani, H.; Catalytic asymmetric synthesis of antimalarial alkaloids febrifubine and isofebrifugine and their biological actvity. J Org Chem 1999, 64, 18, 6833.
|
【2】
Kobayashi, S.; Kim, H.-S.; Wataya, Y. (Japan Science and Technology Corp.); Febrifugine and isofebrifugine and processes for the preparation of both. EP 1076057; WO 0052005 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(A) |
11990 |
Di(1H-imidazol-1-yl)methanethione; 1,1'-Thiocarbonyldiimidazole
|
6160-65-2 |
C7H6N4S |
详情 | 详情
|
(I) |
44768 |
4-[[tert-butyl(dimethyl)silyl]oxy]-2-butanone
|
|
C10H22O2Si |
详情 |
详情
|
(II) |
44769 |
benzyl (Z)-2-phenoxy-2-[(trimethylsilyl)oxy]ethenyl ether; [[(Z)-2-(benzyloxy)-1-phenoxyethenyl]oxy](trimethyl)silane
|
|
C18H22O3Si |
详情 |
详情
|
(III) |
44770 |
N-[[(2S)-1-methylpyrrolidinyl]methyl]-N-(1-naphthyl)amine; N-[[(2S)-1-methylpyrrolidinyl]methyl]-1-naphthalenamine
|
82160-07-4 |
C16H20N2 |
详情 | 详情
|
(IV) |
44771 |
phenyl (2S,3R)-2-(benzyloxy)-5-[[tert-butyl(dimethyl)silyl]oxy]-3-hydroxypentanoate
|
|
C24H34O5Si |
详情 |
详情
|
(V) |
44773 |
phenyl (2S)-2-(benzyloxy)-5-[[tert-butyl(dimethyl)silyl]oxy]pentanoate
|
|
C24H34O4Si |
详情 |
详情
|
(VI) |
44774 |
(2S)-2-(benzyloxy)-5-[[tert-butyl(dimethyl)silyl]oxy]pentanal
|
|
C18H30O3Si |
详情 |
详情
|
(VII) |
17354 |
isopropenyl methyl ether; 2-methoxy-1-propene
|
116-11-0 |
C4H8O |
详情 | 详情
|
(VIII) |
25193 |
2-methoxyphenylamine; 2-methoxyaniline
|
517-28-2 |
C7H9NO |
详情 | 详情
|
(IX) |
44777 |
|
|
C27H42NO4Si |
详情 |
详情
|
(X) |
44778 |
1-[(2R,3S)-3-(benzyloxy)-1-(2-methoxyphenyl)piperidinyl]acetone
|
|
C22H27NO3 |
详情 |
详情
|
(XI) |
44779 |
1-[(2R,3S)-3-(benzyloxy)piperidinyl]acetone
|
|
C15H21NO2 |
详情 |
详情
|
(XII) |
44780 |
1-methoxy-4-(3-methoxy-3-butenyl)benzene; 4-(3-methoxy-3-butenyl)phenyl methyl ether
|
|
C12H16O2 |
详情 |
详情
|
(XIII) |
44781 |
|
|
C35H50NO5Si |
详情 |
详情
|
(XIV) |
44782 |
tert-butyl (2R,3S)-3-(benzyloxy)-2-(3-bromo-2-oxopropyl)-1-piperidinecarboxylate
|
|
C20H28BrNO4 |
详情 |
详情
|
(XV) |
44783 |
4-quinazolinol
|
|
C8H6N2O |
详情 |
详情
|
合成路线14
该中间体在本合成路线中的序号:
(III) Alternatively, 2-amino-5-bromopyridine (I) was reacted with 1,1'-thiocarbonyldiimidazole (III) in acetonitrile yielding thioimidazolide (IV), which was then condensed with 2-(1-cyclohexenyl)ethylamine (V) in hot DMF.
【1】
Maher, D.; Mao, C.; Pendergrass, S.; Venkatachalam, T.K.; Zhu, D.; Tuel-Ahlgren, L.; Uckun, F.M.; N-[2-(1-Cyclohexenyl)ethyl]-N'-[2-(5-bromopyridyl)]-thiourea and N'-[2-(1-cyclohexenyl)ethyl]-N'-[2-(5-chloropyridyl)]-thiourea as potent inhibitors of multidrug-resistant human immunodeficiency virus-1. Bioorg Med Chem Lett 1999, 9, 18, 2721. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
12123 |
5-Bromo-2-pyridinylamine; 5-Bromo-2-pyridinamine; 2-Amino-5-bromopyridine
|
1072-97-5 |
C5H5BrN2 |
详情 | 详情
|
(III) |
11990 |
Di(1H-imidazol-1-yl)methanethione; 1,1'-Thiocarbonyldiimidazole
|
6160-65-2 |
C7H6N4S |
详情 | 详情
|
(IV) |
24645 |
N-(5-bromo-2-pyridinyl)-1H-imidazole-1-carbothioamide
|
|
C9H7BrN4S |
详情 |
详情
|
(V) |
36902 |
2-(1-cyclohexen-1-yl)ethylamine; 2-(1-cyclohexen-1-yl)-1-ethanamine; 2-(1-Cyclohexenyl)ethylamine
|
3399-73-3 |
C8H15N |
详情 | 详情
|
合成路线15
该中间体在本合成路线中的序号:
(III) Alternatively, 2-amino-5-chloropyridine (I) was reacted with 1,1'-thiocarbonyldiimidazole (III) in acetonitrile yielding thioimidazolide (IV), which was then condensed with 2-(1-cyclohexenyl)ethylamine (V) in hot DMF.
【1】
Maher, D.; Mao, C.; Pendergrass, S.; Venkatachalam, T.K.; Zhu, D.; Tuel-Ahlgren, L.; Uckun, F.M.; N-[2-(1-Cyclohexenyl)ethyl]-N'-[2-(5-bromopyridyl)]-thiourea and N'-[2-(1-cyclohexenyl)ethyl]-N'-[2-(5-chloropyridyl)]-thiourea as potent inhibitors of multidrug-resistant human immunodeficiency virus-1. Bioorg Med Chem Lett 1999, 9, 18, 2721. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
18559 |
5-Chloro-2-pyridinylamine; 5-Chloro-2-pyridinamine; 2-Amino-5-chloropyridine
|
1072-98-6 |
C5H5ClN2 |
详情 | 详情
|
(III) |
11990 |
Di(1H-imidazol-1-yl)methanethione; 1,1'-Thiocarbonyldiimidazole
|
6160-65-2 |
C7H6N4S |
详情 | 详情
|
(IV) |
36903 |
|
|
C9H7ClN4S |
详情 |
详情
|
(V) |
36902 |
2-(1-cyclohexen-1-yl)ethylamine; 2-(1-cyclohexen-1-yl)-1-ethanamine; 2-(1-Cyclohexenyl)ethylamine
|
3399-73-3 |
C8H15N |
详情 | 详情
|
合成路线16
该中间体在本合成路线中的序号:
(II) Reaction of 2-amino-5-bromopyridine (I) with thiocarbonyl diimidazole (II) provided the thioimidazolide (III). This was then coupled with 2-(2-thienyl)ethyl amine (IV) to furnish the target thiourea.
【1】
Maher, D.; Mao, C.; Tuel-Ahlgren, L.; Uckun, F.M.; Zhu, D.; Pendergrass, S.; Venkatachalam, T.K.; N'-[2-(2-Thiophene)ethyl]-N'-[2-(5-bromopyridyl)] thiourea as a potent inhibitor of NNI-resistant and multidrug-resistant human immunodeficiency virus-1. Bioorg Med Chem Lett 1999, 9, 24, 3411. |
【2】
Ventatachalam, T.K.; Uckun, F.M. (Parker Hughes Institute); Thiophene-ethyl thiourea cpds. and use. US 6124324; WO 0078755 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
12123 |
5-Bromo-2-pyridinylamine; 5-Bromo-2-pyridinamine; 2-Amino-5-bromopyridine
|
1072-97-5 |
C5H5BrN2 |
详情 | 详情
|
(II) |
11990 |
Di(1H-imidazol-1-yl)methanethione; 1,1'-Thiocarbonyldiimidazole
|
6160-65-2 |
C7H6N4S |
详情 | 详情
|
(III) |
24645 |
N-(5-bromo-2-pyridinyl)-1H-imidazole-1-carbothioamide
|
|
C9H7BrN4S |
详情 |
详情
|
(IV) |
35253 |
2-(2-thienyl)ethylamine; 2-(2-thienyl)-1-ethanamine; 2-Thiophene ethylamine
|
30433-91-1 |
C6H9NS |
详情 | 详情
|
合成路线17
该中间体在本合成路线中的序号:
(IV) 2-Phenyl-3,4-dihydro-2H-1-benzothiopyran-4-one (I) was converted to oxime (II) upon treatment with hydroxylamine, and subsequently reduced to amine (III) by means of Zn and HOAc. Condensation of (III) with thiocarbonyl diimidazole (IV) produced the thioimidazolide (V), that was displaced with 2-bromoethyl amine (VI) to furnish thiourea (VII). Finally, cyclization of the N-(bromoethyl)thiourea (VII) in the presence of Et3N produced the target thiazoline derivative.
【1】
Lewis, J.J.; Bare, T.M.; Horchler, C.L.; et al.; Selective alpha2C-adrenoceptor agonist activity of imidazole, imidazoline, and imidazoline-related derivatives. 219th ACS Natl Meet (March 26 2000, San Francisco) 2000, Abst MEDI 268.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
41083 |
2-phenyl-2,3-dihydro-4H-thiochromen-4-one
|
|
C15H12OS |
详情 |
详情
|
(II) |
41084 |
2-phenyl-2,3-dihydro-4H-thiochromen-4-one oxime
|
|
C15H13NOS |
详情 |
详情
|
(III) |
41085 |
2-phenyl-4-thiochromanamine; 2-phenyl-3,4-dihydro-2H-thiochromen-4-ylamine
|
|
C15H15NS |
详情 |
详情
|
(IV) |
11990 |
Di(1H-imidazol-1-yl)methanethione; 1,1'-Thiocarbonyldiimidazole
|
6160-65-2 |
C7H6N4S |
详情 | 详情
|
(V) |
41086 |
N-(2-phenyl-3,4-dihydro-2H-thiochromen-4-yl)-1H-imidazole-1-carbothioamide
|
|
C19H17N3S2 |
详情 |
详情
|
(VI) |
38475 |
2-bromoethylamine; 2-bromo-1-ethanamine
|
|
C2H6BrN |
详情 |
详情
|
(VII) |
41087 |
N-(2-bromoethyl)-N'-(2-phenyl-3,4-dihydro-2H-thiochromen-4-yl)thiourea
|
|
C18H19BrN2S2 |
详情 |
详情
|
合成路线18
该中间体在本合成路线中的序号:
(III) 2-Amino-5-chloropyridine-3-sulfonamide (II) was obtained by the reaction of 2-amino-5-chloropyridine (I) with chlorosulfonic acid, followed by treatment of the sulfonyl chloride intermediate with aqueous ammonia. Condensation of amino sulfonamide (II) with thiocarbonyldiimidazole (III) produced the imidazolyl pyridothiadiazine (IV). Nucleophilic substitution of the imidazolyl group with 1,2,2-trimethylpropylamine (V) in a sealed vessel at 180 C furnished the corresponding amino pyridothiadiazine.
【1】
de Tullio, P.; Quedraogo, R.; Pirotte, B.; et al.; 3-Alkylamino-4H-pyrido[2,3-e]-1,2,4-thiadiazine 1,1-dioxides structurally related to diazoxide and pinacidil as potassium channel openers acting on vascular smooth muscle cells: Design, synthesis, and pharmacological evaluation. J Med Chem 2000, 43, 8, 1456. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
18559 |
5-Chloro-2-pyridinylamine; 5-Chloro-2-pyridinamine; 2-Amino-5-chloropyridine
|
1072-98-6 |
C5H5ClN2 |
详情 | 详情
|
(II) |
46289 |
2-amino-5-chloro-3-pyridinesulfonamide
|
|
C5H6ClN3O2S |
详情 |
详情
|
(III) |
11990 |
Di(1H-imidazol-1-yl)methanethione; 1,1'-Thiocarbonyldiimidazole
|
6160-65-2 |
C7H6N4S |
详情 | 详情
|
(IV) |
46290 |
7-chloro-3-(1H-imidazol-1-yl)-2H-pyrido[2,3-e][1,2,4]thiadiazine-1,1(4H)-dione |
|
C9H6ClN5O2S |
详情 |
详情
|
(V) |
30977 |
(2R)-3,3-dimethyl-2-butanamine; (1R)-1,2,2-trimethylpropylamine
|
|
C6H15N |
详情 |
详情
|
合成路线19
该中间体在本合成路线中的序号:
(II) Reaction of 2-amino-5-bromopyridine (I) with thiocarbonyldiimidazole (II) afforded the thioimidazolide (III). This was then condensed with 4-methylphenetylamine (IV) in hot DMF to produce the required thiourea.
【2】
Ventalachalam, T.K.; Uckum, F.M. (Parker Hughes Institute); Phenethyl-thiourea cpds. and use. US 6207688 .
|
【1】
Uckun, F.M.; Zhu, D.; Pendergrass, S.; Mao, C.; Tuel-Ahlgren, L.; Venkatachalam, T.K.; Maher, D.; N-[2-(4-Methylphenyl)ethyl]-N'-[2-(5-bromopyridyl)]thiourea as a potent inhibitor of NNRTI-resistant and multidrug-resistant human immunodeficiency virus type 1. Antivir Chem Chemother 2000, 11, 2, 135. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
12123 |
5-Bromo-2-pyridinylamine; 5-Bromo-2-pyridinamine; 2-Amino-5-bromopyridine
|
1072-97-5 |
C5H5BrN2 |
详情 | 详情
|
(II) |
11990 |
Di(1H-imidazol-1-yl)methanethione; 1,1'-Thiocarbonyldiimidazole
|
6160-65-2 |
C7H6N4S |
详情 | 详情
|
(III) |
24645 |
N-(5-bromo-2-pyridinyl)-1H-imidazole-1-carbothioamide
|
|
C9H7BrN4S |
详情 |
详情
|
(IV) |
46291 |
4-methylphenethylamine; 2-(4-methylphenyl)-1-ethanamine
|
|
C9H13N |
详情 |
详情
|
合成路线20
该中间体在本合成路线中的序号:
(II) Condensation of 2-amino-5-bromopyridine (I) with thiocarbonyl diimidazole (II) gave rise to thioimidazolide (III), which was then condensed with (R)-1-phenylethylamine (IV) to yield the title thiourea.
【1】
Mao, C.; Venkatachalam, T.K.; Uckun, F.M.; Sudbeck, E.A.; Stereochemistry of halopyridyl and thiazolyl thiourea compounds is a major determinant of their potency as nonnucleoside inhibitors of HIV-1 reverse transcriptase. Bioorg Med Chem Lett 2000, 10, 18, 2071. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
12123 |
5-Bromo-2-pyridinylamine; 5-Bromo-2-pyridinamine; 2-Amino-5-bromopyridine
|
1072-97-5 |
C5H5BrN2 |
详情 | 详情
|
(II) |
11990 |
Di(1H-imidazol-1-yl)methanethione; 1,1'-Thiocarbonyldiimidazole
|
6160-65-2 |
C7H6N4S |
详情 | 详情
|
(III) |
24645 |
N-(5-bromo-2-pyridinyl)-1H-imidazole-1-carbothioamide
|
|
C9H7BrN4S |
详情 |
详情
|
(IV) |
10039 |
(1R)-1-Phenylethylamine; (1R)-1-Phenyl-1-ethanamine.; L-alpha-Phenylethylamine
|
3886-69-9 |
C8H11N |
详情 | 详情
|
合成路线21
该中间体在本合成路线中的序号:
(II) Reaction of 2-aminothiazole (I) with thiocarbonyldiimidazole (II) in acetonitrile gave the intermediate thioimidazolide (III). This was then condensed with 2-furylmethylamine (IV) in hot DMF to yield the title thiourea derivative.
【1】
Venkatachalam, T.K.; Sudbeck, E.A.; Mao, C.; Uckun, F.M.; Anti-HIV activity of aromatic and heterocyclic thiazolyl thiourea compounds. Bioorg Med Chem Lett 2001, 11, 4, 523.
|
【2】
Uckun, F.M.; Venkatachalam, T.K. (Parker Hughes Institute); Aromatic and heterocyclic thiazolyl thiourea cpds. and use. WO 0232889 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
19795 |
2-Thiazolamine; 1,3-thiazol-2-amine; 1,3-thiazol-2-ylamine
|
96-50-4 |
C3H4N2S |
详情 | 详情
|
(II) |
11990 |
Di(1H-imidazol-1-yl)methanethione; 1,1'-Thiocarbonyldiimidazole
|
6160-65-2 |
C7H6N4S |
详情 | 详情
|
(III) |
51395 |
N-(1,3-thiazol-2-yl)-1H-imidazole-1-carbothioamide
|
|
C7H6N4S2 |
详情 |
详情
|
(IV) |
51396 |
1-(2-Furyl)methylamine; 2-Aminomethylfuran; 2-Furfurylamine; Furfurylamine
|
617-89-0 |
C5H7NO |
详情 | 详情
|
合成路线22
该中间体在本合成路线中的序号:
(III) 2,6-Difluorophenethylamine (II) was prepared by reduction of nitrile (I) with either NaBH4 in the presence of CoCl2 or borane in THF. Reaction of amine (II) with thiocarbonyldiimidazole (III) furnished the thioimidazolide (IV). This was finally condensed with 2-amino-5-chloropyridine (V), yielding the corresponding thiourea.
【1】
Lind, P.T.; Noreen, R.; Ternansky, R.J.; Morin, J.M. Jr. (Medivir AB); Cpds. and methods for inhibition of HIV and related viruses. WO 9303022 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
46429 |
2-(2,6-difluorophenyl)acetonitrile
|
|
C8H5F2N |
详情 |
详情
|
(II) |
46430 |
2-(2,6-difluorophenyl)-1-ethanamine; 2,6-difluorophenethylamine
|
|
C8H9F2N |
详情 |
详情
|
(III) |
11990 |
Di(1H-imidazol-1-yl)methanethione; 1,1'-Thiocarbonyldiimidazole
|
6160-65-2 |
C7H6N4S |
详情 | 详情
|
(IV) |
46431 |
N-(2,6-difluorophenethyl)-1H-imidazole-1-carbothioamide
|
|
C12H11F2N3S |
详情 |
详情
|
(V) |
18559 |
5-Chloro-2-pyridinylamine; 5-Chloro-2-pyridinamine; 2-Amino-5-chloropyridine
|
1072-98-6 |
C5H5ClN2 |
详情 | 详情
|
合成路线23
该中间体在本合成路线中的序号:
(V) 2-(2-Thienyl)ethylamine (I) was protected as the N-Boc derivative (II) with Boc2O in CHCl3. Regioselective halogenation of the thiophene ring of (II) with concomitant Boc group cleavage by means of bromine in cold HOAc yielded the 5-bromothiophene (III). The thioimidazolide (VI) was prepared by reaction of 2-amino-5-chloropyridine (IV) with thiocarbonyl diimidazole (V). Finally, condensation of (VI) with amine (III) in hot DMF furnished the target thiourea.
【1】
Uckun, F.M.; Sudbeck, E.A.; Venkatachalam, T.K.; Regiospecific synthesis, X-ray crystal structure and biological activities of 5-bromothiophenethyl thioureas. Tetrahedron Lett 2001, 42, 38, 6629.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
35253 |
2-(2-thienyl)ethylamine; 2-(2-thienyl)-1-ethanamine; 2-Thiophene ethylamine
|
30433-91-1 |
C6H9NS |
详情 | 详情
|
(II) |
52887 |
tert-butyl 2-(2-thienyl)ethylcarbamate
|
|
C11H17NO2S |
详情 |
详情
|
(III) |
52888 |
2-(5-bromo-2-thienyl)-1-ethanamine; 2-(5-bromo-2-thienyl)ethylamine
|
|
C6H8BrNS |
详情 |
详情
|
(IV) |
18559 |
5-Chloro-2-pyridinylamine; 5-Chloro-2-pyridinamine; 2-Amino-5-chloropyridine
|
1072-98-6 |
C5H5ClN2 |
详情 | 详情
|
(V) |
11990 |
Di(1H-imidazol-1-yl)methanethione; 1,1'-Thiocarbonyldiimidazole
|
6160-65-2 |
C7H6N4S |
详情 | 详情
|
(VI) |
36903 |
|
|
C9H7ClN4S |
详情 |
详情
|
合成路线24
该中间体在本合成路线中的序号:
(V) Conjugate addition of acrylonitrile (II) to 4-phenylpiperidine (I) affords the piperidinopropionitrile (III). Catalytic hydrogenation of the cyano group of (III) in the presence of Raney nickel and methanolic ammonia leads to diamine (IV). This is further converted into isothiocyanate (VI) by reaction with thiocarbonyl diimidazole (V). Subsequent addition of sodium cyanamide to isothiocyanate (VI) yields the intermediate N-cyano isothiourea sodium salt (VII).
【1】
Poindexter, G.S.; Sit, S.-Y.; Swann, R.T.; Bruce, M.A.; Morton, M.A.; Huang, Y.; Breitenbucher, J.G. (Bristol-Myers Squibb Co.); Dihydropyridine NPY antagonists: Cyanoguanidine derivs.. US 6001836; WO 9854136 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
58479 |
4-phenylpiperidine
|
771-99-3 |
C11H15N |
详情 | 详情
|
(II) |
10847 |
Acrylonitrile
|
107-13-1 |
C3H3N |
详情 | 详情
|
(III) |
58480 |
3-(4-phenyl-1-piperidinyl)propanenitrile
|
|
C14H18N2 |
详情 |
详情
|
(IV) |
58481 |
3-(4-phenyl-1-piperidinyl)-1-propanamine; 3-(4-phenyl-1-piperidinyl)propylamine
|
|
C14H22N2 |
详情 |
详情
|
(V) |
11990 |
Di(1H-imidazol-1-yl)methanethione; 1,1'-Thiocarbonyldiimidazole
|
6160-65-2 |
C7H6N4S |
详情 | 详情
|
(VI) |
58482 |
1-(3-isothiocyanatopropyl)-4-phenylpiperidine; 3-(4-phenyl-1-piperidinyl)propyl isothiocyanate
|
|
C15H20N2S |
详情 |
详情
|
(VII) |
58483 |
sodium 1-(3-{[(cyanoimino)(sulfido)methyl]amino}propyl)-4-phenylpiperidine
|
|
C16H21N4NaS |
详情 |
详情
|